Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387127551> ?p ?o ?g. }
- W4387127551 abstract "Bladder cancer is one of the most common malignancies in the urinary system, with high risk of recurrence and progression. However, the difficulty in detecting small tumor lesions and the lack of selectivity of intravesical treatment seriously affect the prognosis of patients with bladder cancer. In the present work, a nanoparticle-based delivery system with tumor targeting, high biocompatibility, simple preparation, and the ability to synergize imaging and therapy was fabricated. Specifically, this nanosystem consisted of the core of doxorubicin (DOX)-loaded polydopamine nanoparticles (PDD NPs) and the shell of hyaluronic acid (HA)-conjugated IR780 (HA-IR780). The HA-IR780-covered PDD NPs (HR-PDD NPs) demonstrated tumor targeting and visualization both in vitro and in vivo with properties of promoted cancer cell endocytosis and lysosomal escape, efficiently delivering drugs to the target site and exerting a killing effect on tumor cells. Encouragingly, intravesical instillation of HR-PDD NPs improved drug retention in the bladder and promoted its accumulation in tumor tissue, resulting in better tumor proliferation inhibition and apoptosis in an orthotopic bladder cancer model in rats. This study provides a promising strategy for the diagnosis and therapy of bladder cancer." @default.
- W4387127551 created "2023-09-29" @default.
- W4387127551 creator A5008190279 @default.
- W4387127551 creator A5015987545 @default.
- W4387127551 creator A5020082199 @default.
- W4387127551 creator A5027862454 @default.
- W4387127551 creator A5028573018 @default.
- W4387127551 creator A5032231952 @default.
- W4387127551 creator A5044890447 @default.
- W4387127551 creator A5046399891 @default.
- W4387127551 creator A5052266746 @default.
- W4387127551 creator A5057203215 @default.
- W4387127551 creator A5068871114 @default.
- W4387127551 date "2023-09-28" @default.
- W4387127551 modified "2023-10-13" @default.
- W4387127551 title "Hyaluronic Acid-Conjugated Fluorescent Probe-Shielded Polydopamine Nanomedicines for Targeted Imaging and Chemotherapy of Bladder Cancer" @default.
- W4387127551 cites W1996076368 @default.
- W4387127551 cites W2046095186 @default.
- W4387127551 cites W2058870872 @default.
- W4387127551 cites W2120102559 @default.
- W4387127551 cites W2293091085 @default.
- W4387127551 cites W2345381093 @default.
- W4387127551 cites W2560401293 @default.
- W4387127551 cites W2568093481 @default.
- W4387127551 cites W2613630131 @default.
- W4387127551 cites W2622957603 @default.
- W4387127551 cites W2733065285 @default.
- W4387127551 cites W2751977655 @default.
- W4387127551 cites W2764210930 @default.
- W4387127551 cites W2770235656 @default.
- W4387127551 cites W2777621232 @default.
- W4387127551 cites W2784109013 @default.
- W4387127551 cites W2789925759 @default.
- W4387127551 cites W2794574048 @default.
- W4387127551 cites W2883552344 @default.
- W4387127551 cites W2903307773 @default.
- W4387127551 cites W2911373426 @default.
- W4387127551 cites W2916183155 @default.
- W4387127551 cites W2917837889 @default.
- W4387127551 cites W2964585156 @default.
- W4387127551 cites W2964957284 @default.
- W4387127551 cites W3048312836 @default.
- W4387127551 cites W3083013802 @default.
- W4387127551 cites W3083721069 @default.
- W4387127551 cites W3083957683 @default.
- W4387127551 cites W3091259827 @default.
- W4387127551 cites W3093835406 @default.
- W4387127551 cites W3126141106 @default.
- W4387127551 cites W3128646645 @default.
- W4387127551 cites W3135875197 @default.
- W4387127551 cites W3184015407 @default.
- W4387127551 cites W3197169053 @default.
- W4387127551 cites W3200041216 @default.
- W4387127551 cites W3208305609 @default.
- W4387127551 cites W4200026971 @default.
- W4387127551 cites W4205754809 @default.
- W4387127551 cites W4205877495 @default.
- W4387127551 cites W4213259654 @default.
- W4387127551 cites W4220724103 @default.
- W4387127551 cites W4283079372 @default.
- W4387127551 cites W4297348182 @default.
- W4387127551 cites W4313489800 @default.
- W4387127551 cites W4322624334 @default.
- W4387127551 cites W4323348795 @default.
- W4387127551 cites W4360807163 @default.
- W4387127551 cites W4377220775 @default.
- W4387127551 cites W4380422340 @default.
- W4387127551 cites W4383872209 @default.
- W4387127551 cites W4385220785 @default.
- W4387127551 doi "https://doi.org/10.1021/acsami.3c09564" @default.
- W4387127551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37769147" @default.
- W4387127551 hasPublicationYear "2023" @default.
- W4387127551 type Work @default.
- W4387127551 citedByCount "0" @default.
- W4387127551 crossrefType "journal-article" @default.
- W4387127551 hasAuthorship W4387127551A5008190279 @default.
- W4387127551 hasAuthorship W4387127551A5015987545 @default.
- W4387127551 hasAuthorship W4387127551A5020082199 @default.
- W4387127551 hasAuthorship W4387127551A5027862454 @default.
- W4387127551 hasAuthorship W4387127551A5028573018 @default.
- W4387127551 hasAuthorship W4387127551A5032231952 @default.
- W4387127551 hasAuthorship W4387127551A5044890447 @default.
- W4387127551 hasAuthorship W4387127551A5046399891 @default.
- W4387127551 hasAuthorship W4387127551A5052266746 @default.
- W4387127551 hasAuthorship W4387127551A5057203215 @default.
- W4387127551 hasAuthorship W4387127551A5068871114 @default.
- W4387127551 hasConcept C105702510 @default.
- W4387127551 hasConcept C121608353 @default.
- W4387127551 hasConcept C126322002 @default.
- W4387127551 hasConcept C150903083 @default.
- W4387127551 hasConcept C170493617 @default.
- W4387127551 hasConcept C171250308 @default.
- W4387127551 hasConcept C182606246 @default.
- W4387127551 hasConcept C191897082 @default.
- W4387127551 hasConcept C192562407 @default.
- W4387127551 hasConcept C207001950 @default.
- W4387127551 hasConcept C2776694085 @default.
- W4387127551 hasConcept C2777230088 @default.
- W4387127551 hasConcept C2777529286 @default.
- W4387127551 hasConcept C2779820397 @default.